- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 8, 2025 | 3.67M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $8.92M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $7.08M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $15.24M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $13.97M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $23.7M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $21.67M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $39.8M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $36.94M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $56.07M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $51.5M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 3.55M sh |
| Capex restated | Q1 2025 · Mar 31, 2024 | $214K |
| Operating Cash Flow restated | Q1 2025 · Mar 31, 2024 | −$786K |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2024 | $21.52M |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | $21.31M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.19 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.19 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $5.31M |
| Net Income restated | Q1 2025 · Mar 31, 2024 | $681K |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $983K |